Copyright Reports & Markets. All rights reserved.

Global Communicable Diseases Drugs Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Communicable Diseases Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Communicable Diseases Drugs Market Size Growth Rate by Product
      • 1.4.2 HIV
      • 1.4.3 Influenza
      • 1.4.4 TB
      • 1.4.5 Malaria
      • 1.4.6 Hepatitis
      • 1.4.7 HPV
    • 1.5 Market by End User
      • 1.5.1 Global Communicable Diseases Drugs Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Communicable Diseases Drugs Market Size
      • 2.1.1 Global Communicable Diseases Drugs Revenue 2014-2025
      • 2.1.2 Global Communicable Diseases Drugs Sales 2014-2025
    • 2.2 Communicable Diseases Drugs Growth Rate by Regions
      • 2.2.1 Global Communicable Diseases Drugs Sales by Regions
      • 2.2.2 Global Communicable Diseases Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Communicable Diseases Drugs Sales by Manufacturers
      • 3.1.1 Communicable Diseases Drugs Sales by Manufacturers
      • 3.1.2 Communicable Diseases Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Communicable Diseases Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Communicable Diseases Drugs Revenue by Manufacturers
      • 3.2.1 Communicable Diseases Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Communicable Diseases Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Communicable Diseases Drugs Price by Manufacturers
    • 3.4 Communicable Diseases Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Communicable Diseases Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Communicable Diseases Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Communicable Diseases Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Communicable Diseases Drugs Sales by Product
    • 4.2 Global Communicable Diseases Drugs Revenue by Product
    • 4.3 Communicable Diseases Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Communicable Diseases Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Communicable Diseases Drugs by Countries
      • 6.1.1 North America Communicable Diseases Drugs Sales by Countries
      • 6.1.2 North America Communicable Diseases Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Communicable Diseases Drugs by Product
    • 6.3 North America Communicable Diseases Drugs by End User

    7 Europe

    • 7.1 Europe Communicable Diseases Drugs by Countries
      • 7.1.1 Europe Communicable Diseases Drugs Sales by Countries
      • 7.1.2 Europe Communicable Diseases Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Communicable Diseases Drugs by Product
    • 7.3 Europe Communicable Diseases Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Communicable Diseases Drugs by Countries
      • 8.1.1 Asia Pacific Communicable Diseases Drugs Sales by Countries
      • 8.1.2 Asia Pacific Communicable Diseases Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Communicable Diseases Drugs by Product
    • 8.3 Asia Pacific Communicable Diseases Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Communicable Diseases Drugs by Countries
      • 9.1.1 Central & South America Communicable Diseases Drugs Sales by Countries
      • 9.1.2 Central & South America Communicable Diseases Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Communicable Diseases Drugs by Product
    • 9.3 Central & South America Communicable Diseases Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Communicable Diseases Drugs by Countries
      • 10.1.1 Middle East and Africa Communicable Diseases Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Communicable Diseases Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Communicable Diseases Drugs by Product
    • 10.3 Middle East and Africa Communicable Diseases Drugs by End User

    11 Company Profiles

    • 11.1 Novartis
      • 11.1.1 Novartis Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Novartis Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Novartis Communicable Diseases Drugs Products Offered
      • 11.1.5 Novartis Recent Development
    • 11.2 Gilead
      • 11.2.1 Gilead Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Gilead Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Gilead Communicable Diseases Drugs Products Offered
      • 11.2.5 Gilead Recent Development
    • 11.3 GSK
      • 11.3.1 GSK Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 GSK Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 GSK Communicable Diseases Drugs Products Offered
      • 11.3.5 GSK Recent Development
    • 11.4 Janssen Pharmaceutical
      • 11.4.1 Janssen Pharmaceutical Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Janssen Pharmaceutical Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Janssen Pharmaceutical Communicable Diseases Drugs Products Offered
      • 11.4.5 Janssen Pharmaceutical Recent Development
    • 11.5 Roche
      • 11.5.1 Roche Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Roche Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Roche Communicable Diseases Drugs Products Offered
      • 11.5.5 Roche Recent Development
    • 11.6 BioCryst Pharmaceuticals
      • 11.6.1 BioCryst Pharmaceuticals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 BioCryst Pharmaceuticals Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 BioCryst Pharmaceuticals Communicable Diseases Drugs Products Offered
      • 11.6.5 BioCryst Pharmaceuticals Recent Development
    • 11.7 Merck
      • 11.7.1 Merck Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Merck Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Merck Communicable Diseases Drugs Products Offered
      • 11.7.5 Merck Recent Development
    • 11.8 Boehringer Ingelheim
      • 11.8.1 Boehringer Ingelheim Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Boehringer Ingelheim Communicable Diseases Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Boehringer Ingelheim Communicable Diseases Drugs Products Offered
      • 11.8.5 Boehringer Ingelheim Recent Development

    12 Future Forecast

    • 12.1 Communicable Diseases Drugs Market Forecast by Regions
      • 12.1.1 Global Communicable Diseases Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Communicable Diseases Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Communicable Diseases Drugs Market Forecast by Product
      • 12.2.1 Global Communicable Diseases Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Communicable Diseases Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Communicable Diseases Drugs Market Forecast by End User
    • 12.4 North America Communicable Diseases Drugs Forecast
    • 12.5 Europe Communicable Diseases Drugs Forecast
    • 12.6 Asia Pacific Communicable Diseases Drugs Forecast
    • 12.7 Central & South America Communicable Diseases Drugs Forecast
    • 12.8 Middle East and Africa Communicable Diseases Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Communicable Diseases Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      In this report, we study the drugs for Communicable Diseases. Communicable diseases are disorders caused by organisms — such as bacteria, viruses,fungi or parasites
      The global Communicable Diseases Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Communicable Diseases Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Communicable Diseases Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Communicable Diseases Drugs in these regions.
      This research report categorizes the global Communicable Diseases Drugs market by top players/brands, region, type and end user. This report also studies the global Communicable Diseases Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Novartis
      Gilead
      GSK
      Janssen Pharmaceutical
      Roche
      BioCryst Pharmaceuticals
      Merck
      Boehringer Ingelheim

      Market size by Product
      HIV
      Influenza
      TB
      Malaria
      Hepatitis
      HPV
      Market size by End User
      Hospital
      Clinic
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Communicable Diseases Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Communicable Diseases Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Communicable Diseases Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Communicable Diseases Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Communicable Diseases Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Communicable Diseases Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now